Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AGCO Corporation (AGCO) vs McKesson Corporation (MCK) Price & Performance

AGCO CorporationTrade
McKesson CorporationTrade

Price performance (Past 24H)

Key statistics

AGCO Corporation vs McKesson Corporation — how do they compare? AGCO Corporation trades at $101.77 (market cap $7.10B), while McKesson Corporation trades at $892.32 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 14.8× AGCO Corporation's market cap, and AGCO Corporation pays the higher dividend (1.18%). Which is the better fit depends on your goals.

AGCOMCK
Market Cap
$7.10B$105.14B
Sector
IndustrialsHealth
52-Week High
$140.49$995.69
52-Week Low
$100.14$659.01
Enterprise Value
$9.37B$111.67B
Dividend Yield
1.18%0.42%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AGCO Corporation

AGCO Corporation (NYSE: AGCO) is trading at $100.87, down 1.91% on the day, following disappointing Q2 2026 earnings that missed expectations. The agricultural equipment manufacturer faces bearish technical signals with support at $99 and resistance at $103. Fundamentally, the company maintains reasonable valuation metrics (P/E 14.03, P/S 0.72) despite recent earnings volatility, with 2025 revenue of $10.08 billion and net income of $726.5 million. Recent leadership changes and multiple securities investigations have created investor uncertainty.

The outlook remains cautious as AGCO navigates weaker industry demand and lowered 2026 guidance. While analyst consensus suggests 23.5% upside to the $124.63 price target, near-term headwinds from agricultural market softness and legal scrutiny present significant risks. The stock's current valuation may offer value for patient investors, but execution risks and market sentiment require careful monitoring.

McKesson Corporation

McKesson (MCK) trades at $879.87, up 1.18% today, with strong momentum from recent earnings beats and raised guidance. The stock shows bullish technical signals, supported by robust revenue growth and solid cash flow generation. Recent news highlights strength in specialty drugs and oncology, driving positive sentiment.

Outlook remains favorable with a consensus price target of $990.67, though thin profit margins and high liabilities pose risks. Continued execution on growth initiatives and cost discipline are key for sustained upside, while macroeconomic pressures and competitive dynamics require monitoring.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AGCO Corporation

Agco is a global manufacturer of agricultural equipment. The company has five principal brands: Fendt, Massey Ferguson, Challenger, Valtra, and GSI. Unlike its competitors, Agco's product line extends beyond self-propelled equipment and implements by offering grain handling systems and livestock management solutions. Its products are available through a global dealer network, which includes over 3,200 dealer and distribution locations. Additionally, Agco offers both retail and wholesale financing to customers through its joint venture with Rabobank, a European food and agriculture focused bank.

Read more on AGCO

About McKesson Corporation

McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Read more on MCK